Welcome to our dedicated page for Cannabist news (Ticker: CBSTF), a resource for investors and traders seeking the latest updates and insights on Cannabist stock.
Cannabist Holdings (CBSTF) delivers cannabis industry innovation through integrated cultivation technologies and compliance-focused operations. This news hub provides investors with essential updates on strategic developments within evolving regulatory frameworks.
Access real-time announcements including earnings reports, partnership agreements, and operational expansions. Our curated collection features regulatory filings, product innovation updates, and market positioning statements directly from corporate sources.
Key coverage areas include:
Financial disclosures: Quarterly results and investment activities
Operational updates: Facility expansions and cultivation advancements
Regulatory compliance: Licensing developments and quality control measures
Strategic partnerships: Technology integrations and distribution alliances
Bookmark this page for streamlined tracking of CBSTF's progress in cannabis product development and market expansion. Regular updates ensure informed decision-making about this dynamic sector participant.
The Cannabist Company (OTCQB: CBSTF) reported Q3 2025 results for the quarter ended September 30, 2025. Revenue was $79.9M, down 7.5% sequentially; adjusted gross margin was 32% (down from 33%); adjusted EBITDA was $3.0M versus $8.5M in Q2. Management cited price compression and wholesale inventory reductions as drivers of margin pressure.
The company continued footprint optimization: opened new retail sites in Ohio, started adult-use sales in Delaware on August 1, sold three Pennsylvania dispensaries (net cash > $8M) and completed sale of Florida leasehold/equipment for $11M in gross proceeds.
Cash balance improved vs prior quarter and capex fell to $0.2M in Q3.
The Cannabist Company (OTCQB: CBSTF) will report third-quarter 2025 financial results for the period ended September 30, 2025 after U.S. markets close on Monday, November 10, 2025.
Company management will host a conference call and live audio webcast at 4:30 p.m. EST the same day. Participants must pre-register for telephone access and will receive dial-in instructions after registering. A live audio webcast will be available in the company Investor Relations section.
The Cannabist Company (OTCQB: CBSTF) announced the opening of Cannabist Saint Clairsville on October 30, 2025, its first dispensary in Belmont County and the company’s seventh dispensary in Ohio.
The store at 51710 National Road East serves both medical patients and adult-use customers, offers flower, pre-rolls, edibles, concentrates, house brands Seed & Strain, Triple Seven, and Classix, and carries select third-party products. The company operates approximately 75,000 square feet of cultivation and manufacturing space in Ohio to support retail and wholesale operations.
The Cannabist Company (OTCQB: CBSTF) announced that co-founder and longtime board member Michael Abbott resigned from the Board, effective October 3, 2025, to pursue other personal and professional commitments.
Abbott co-founded the company (originally Columbia Care) in 2012, served as Executive Chairman until 2023, and had served as Chair of the Board since then. CEO and director David Hart thanked Abbott for his contributions and wished him well.
The Cannabist Company (OTCQB: CBSTF) has announced a strategic partnership with Queen Mary, an award-winning California wellness-focused cannabis brand, to launch rosin-infused gummies in Colorado. The products will be available at all 19 Cannabist Company retail locations across the state.
Founded by Colorado native Tiana Woodruff, Queen Mary specializes in premium edibles made with full-spectrum rosin, adaptogens, and natural vitamins. The initial product lineup includes Enchanted gummies (Strawberry Lemonade) for focus and energy, and Moonstruck gummies (Lavender Blueberry) for relaxation and sleep. A Boost tincture will launch next month.
The partnership includes plans for wholesale distribution to additional Colorado dispensaries beginning in October through The Cannabist Company's distribution network.
The Cannabist Company Holdings (OTCQB: CBSTF), a leading U.S. cannabis cultivator, manufacturer, and retailer, held its annual general meeting on September 24, 2025. All seven director nominees were successfully elected to the board, with Peter Lee and Thomas Lynch receiving the highest approval rates of approximately 86.7% each.
Shareholders also approved the re-appointment of PKF O'Connor Davies LLP as the company's auditor and authorized directors to determine their compensation. The voting results have been filed on SEDAR+.
The Cannabist Company (CBSTF) announced the grand opening of Cannabist Norwalk, its sixth dispensary in Ohio, scheduled for September 10, 2025. Located at 383 Milan Avenue, this marks the company's first Cannabist-branded dispensary in Ohio and the first cannabis dispensary in Huron County.
The dual-use licensed location will serve both medical patients and adult-use customers, offering a diverse product range including house brands like Classix, Seed & Strain, and Triple Seven, alongside over 100 third-party brands. The company plans to open its seventh Ohio location in Saint Clairsville later in 2025, expanding its retail presence throughout the state.
The Cannabist Company (OTCQB: CBSTF) has expanded its partnership with COAST Cannabis Co. by launching COAST's gummy products in New Jersey. This expansion follows their successful collaboration in Maryland. The products are being manufactured at Cannabist's Vineland facility using their premium cannabis oil and COAST's proprietary formulations.
The launch introduces eight wellness-focused gummy varieties including Energy, Balance, Relax, Recovery, Sleep, Sleep & Recovery, and Deep Sleep formulations. These products are now available at Cannabist locations in Deptford, Mays Landing, and Vineland. COAST's gummies are distinguished by their use of organic ingredients and absence of artificial additives or high-fructose corn syrup.
The Cannabist Company (OTCQB: CBSTF) has completed the sale of its Pennsylvania affiliate, which operates 3 medical dispensaries, to VP Investment Holdings for $10 million in cash. The strategic transaction includes a concurrent supply agreement with VP Holdings for products from Cannabist's grow/processing facility, gLeaf.
The dispensaries, located in Scranton, Allentown, and Wilkes-Barre, will be rebranded under the Restore brand. This move aligns with Cannabist's strategy to simplify operations and optimize assets, transitioning to a wholesale-focused model in Pennsylvania while leveraging their Saxton cultivation facility.
The Cannabist Company (OTCQB: CBSTF) reported Q2 2025 financial results with revenue of $86.4 million, down 1% quarter-over-quarter and 31% year-over-year. The company achieved Adjusted EBITDA of $8.5 million with a margin improvement of 30 basis points to 9.8%.
Key developments include completing a debt restructuring extending senior debt maturities to December 2028, selling Florida assets for $5 million, and announcing the sale of three Pennsylvania dispensaries for $10 million. The company launched adult-use sales in Delaware and implemented corporate restructuring for $2 million in annual cost savings.
Wholesale revenue grew 16% sequentially to $18.4 million, representing 21% of total revenue. The company operated 53 retail locations at quarter-end and maintained $15.5 million in cash.
FAQ
What is the current stock price of Cannabist (CBSTF)?
What is the market cap of Cannabist (CBSTF)?
